The Therapeutic Products Directorate (TPD) of the Health Products and Food Branch of Health Canada is implementing an Integrated Review Process of Abbreviated New Drug Submissions (ANDSs), starting with all new submissions received by the Submission Information and Policy Division as of January 1, 2008. Health Canada anticipates that performing a pre-evaluation of ANDSs will ensure a more effective and efficient review process by identifying and addressing significant deficiencies prior to the review process, which will ultimately reduce the numbers of Notices of Deficiency (NODs) and Notices of Non-compliance (NONs) issued, as well as decreasing the review cycle time.

For more information, please see: